Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
515,345,024
-
Share change
-
-6,464,036
-
Total reported value
-
$30,452,110,183
-
Put/Call ratio
-
72%
-
Price per share
-
$59.10
-
Number of holders
-
813
-
Value change
-
-$418,903,526
-
Number of buys
-
335
-
Number of sells
-
408
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2015
As of 30 Jun 2015,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
813 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
515,345,024 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, Invesco Ltd., LAZARD ASSET MANAGEMENT LLC, WADDELL & REED FINANCIAL INC, Mondrian Investment Partners LTD, BlackRock Advisors LLC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, Allianz Asset Management AG, and PointState Capital LP.
This page lists
813
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.